
PharmaCord Launches in Louisville
The new company links and manages aspects of treatment delivery, facilitating access for patients to treatments by serving as a connector between manufacturers, patients, physicians, and payors.
“As an independently owned, fully funded company, we are developing the technology and tools to provide biopharmaceutical manufacturers with efficient solutions to address the barriers of access for specialty products treating chronic diseases,” said Nitin Sahney, the founder and CEO of PharmaCord, in a
Source:
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.